Syndax Pharmaceuticals (SNDX) Research & Development: 2015-2024
Historic Research & Development for Syndax Pharmaceuticals (SNDX) over the last 10 years, with Dec 2024 value amounting to $241.6 million.
- Syndax Pharmaceuticals' Research & Development rose 63.36% to $15.5 million in Q4 2020 from the same period last year, while for Dec 2020 it was $50.4 million, marking a year-over-year increase of 17.31%. This contributed to the annual value of $241.6 million for FY2024, which is 48.22% up from last year.
- As of FY2024, Syndax Pharmaceuticals' Research & Development stood at $241.6 million, which was up 48.22% from $163.0 million recorded in FY2023.
- In the past 5 years, Syndax Pharmaceuticals' Research & Development registered a high of $241.6 million during FY2024, and its lowest value of $50.4 million during FY2020.
- In the last 3 years, Syndax Pharmaceuticals' Research & Development had a median value of $163.0 million in 2023 and averaged $174.4 million.
- Data for Syndax Pharmaceuticals' Research & Development shows a peak YoY surged of 74.97% (in 2021) over the last 5 years.
- Over the past 5 years, Syndax Pharmaceuticals' Research & Development (Yearly) stood at $50.4 million in 2020, then surged by 74.97% to $88.2 million in 2021, then skyrocketed by 34.28% to $118.5 million in 2022, then spiked by 37.58% to $163.0 million in 2023, then skyrocketed by 48.22% to $241.6 million in 2024.